Evidence map›Paper›PMID 23065277›Full record

ArticleMolecular biology reports2013

Vitamin D receptor gene BsmI, FokI, ApaI and TaqI polymorphisms and the risk of systemic lupus erythematosus.

Adrianna Mostowska, Margarita Lianeri, Mariusz Wudarski, Marzena Olesińska, Paweł P Jagodziński

Open access · hybridAbstract read
In one paragraph

Article in Molecular biology reports, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 4 pooled it
3.8field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 4 syntheses or guidelines pooled it, 72 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Polymorphisms in the vitamin D receptor gene and the lung cancer risk.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2014
    Pooled it
  5. Review
  6. Article
  7. Article
  8. Vitamin D and Glomerulonephritis.Medicina (Kaunas, Lithuania) · 2021
    Review
  9. Disease markers · 2021
    Article
  10. Review
  11. 1,25-(OH)Cell communication and signaling : CCS · 2019
    Article
  12. Article
  13. Article
  14. Article
  15. Effects of 1,25(OH)Journal of cellular and molecular medicine · 2017
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Adrianna MostowskaDepartment of Biochemistry and Molecular Biology, Poznań University of Medical Sciences, 6 Święcickiego St, 60-781, Poznan, Poland.
Margarita Lianeri
Mariusz Wudarski
Marzena Olesińska
Paweł P Jagodziński
Heliodor Swiecicki Clinical Hospital · PLNational Institute of Geriatrics, Rheumatology and Rehabilitation · PLPoznan University of Medical Sciences · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recently, several studies have demonstrated the role of vitamin D receptor (VDR) polymorphisms in the development of systemic lupus erythematosus (SLE); however, these results are inconsistent between different cohorts. Therefore, we studied the prevalence of the VDR FokI (rs2228570), BsmI (rs1544410), ApaI (rs7975232) and TaqI (rs731236) genotypes and alleles in SLE patients (n = 258) and healthy individuals (n = 545) in a Polish population. We did not observe significant differences for either the VDR FokI, BsmI, ApaI and TaqI genotype and allele frequencies in patients with SLE and healthy individuals. However, the frequency of the VDR F/F and F/f genotypes of FokI was statistically different between patients with renal disease and patients without this symptom OR = 3.228 (1.534-6.792, p = 0.0014), p (corr) = 0.0476)]. There was no association of the studied VDR BsmI, ApaI and TaqI polymorphisms with clinical manifestations and laboratory profiles in patients with SLE. Our study indicates that the studied VDR FokI variant might increase the risk of some clinical presentations in patients with SLE.

Indexed as

AdultAmplified Fragment Length Polymorphism AnalysisCase-Control StudiesDeoxyribonucleases, Type II Site-SpecificFemaleGenetic Association StudiesGenetic Predisposition to DiseaseGenotyping TechniquesHumansLupus Erythematosus, SystemicMiddle AgedOdds RatioPolymorphism, Restriction Fragment LengthReceptors, CalcitriolRiskDeoxyribonucleases, Type II Site-Specificendodeoxyribonuclease BsmIendodeoxyribonuclease FokIGGGCCC-specific type II deoxyribonucleasesReceptors, CalcitriolTCGA-specific type II deoxyribonucleases

Identifiers

PMID23065277
PMCPMC3538008
OpenAlexW2032510571

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.